Novo Nordisk
NVO
#14
Rank
$546.76 B
Marketcap
$122.23
Share price
-1.02%
Change (1 day)
70.52%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

P/S ratio for Novo Nordisk (NVO)

P/S ratio as of February 2024 (TTM): 16.1

According to Novo Nordisk's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 16.133. At the end of 2023 the company had a P/S ratio of 13.6.

P/S ratio history for Novo Nordisk from 2001 to 2023

PS ratio at the end of each year

Year P/S ratio Change
202313.612.21%
202212.24.89%
202111.640.15%
20208.278.61%
20197.6119.98%
20186.35-16.63%
20177.6133.98%
20165.68-40.33%
20159.5231.16%
20147.266.83%
20136.791.79%
20126.6822.64%
20115.44-13.47%
20106.2950.04%
20094.1917.18%
20083.58-32.99%
20075.3433.24%
20064.0121.24%
20053.31-9.26%
20043.649.09%
20033.3418%
20022.83-28.15%
20013.94

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
2.22-86.27%๐Ÿ‡บ๐Ÿ‡ธ USA
21.3 32.03%๐Ÿ‡บ๐Ÿ‡ธ USA
2.47-84.70%๐Ÿ‡ซ๐Ÿ‡ท France
2.27-85.93%๐Ÿ‡บ๐Ÿ‡ธ USA